Home Considering a new standard of care in schizophrenia As a psychiatrist, I have observed that schizophrenia is a widely known, but poorly understood mental health condition.
News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
